[Form 4] MYERS INDUSTRIES INC Insider Trading Activity
Samantha Rutty, EVP and CFO of Myers Industries, was granted equity awards on 09/22/2025. The grant includes 19,221 restricted stock units (RSUs) that vest in two equal annual installments on 09/22/2026 and 09/22/2027, and 19,221 performance stock units (PSUs) tied to cumulative adjusted earnings per share over a three-year performance period ending 12/31/2027 with a relative total shareholder return modifier. Each unit represents a contingent right to receive one share of the company’s common stock. Following these grants, the reporting person beneficially owns 19,221 shares from RSUs and 19,221 shares from PSUs, all held directly. The Form 4 was signed by an attorney-in-fact on 09/23/2025.
- Grants include performance-based units tied to cumulative adjusted EPS with a relative TSR modifier, aligning executive pay with long-term performance
- RSUs provide time-based retention with clear vesting dates (09/22/2026 and 09/22/2027)
- None.
Insights
TL;DR: Executive awarded time-vested RSUs and performance-based PSUs to align pay with multi-year performance.
The package combines time-based vesting (two equal annual installments for RSUs) with performance-based awards (PSUs tied to three-year cumulative adjusted EPS and relative TSR modifier), which is a common design to balance retention and pay-for-performance. The disclosed amounts are 19,221 RSUs and 19,221 PSUs, each representing one share if earned or vested. Documentation shows direct ownership post-grant. Without company-level context (total outstanding shares or prior grants) the materiality for shareholders cannot be precisely measured from this Form 4 alone.
TL;DR: Filing correctly reports grant details and vesting/performance conditions; procedural signature is provided.
The Form 4 discloses transaction date (09/22/2025), award types, quantities, vesting schedule for RSUs, and the PSU performance period ending 12/31/2027 with a TSR modifier. The signature by an attorney-in-fact on 09/23/2025 completes the filing formalities. The disclosure is detailed for the granted instruments but does not include grant valuation or the issuer’s total share count, limiting assessment of dilution or compensation magnitude.